Selected research
Industry Growth & Trends
Global Personalized Psychiatry Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Personalized Psychiatry market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Personalized Psychiatry is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Personalized Psychiatry is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Personalized Psychiatry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Personalized Psychiatry market include COMPASS Pathways, Mindstrong Health, Pear Therapeutics, Cogito, Kaia Health, Sooma, GenoMind, Empatica and Akili Interactive, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Personalized Psychiatry market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Personalized Psychiatry market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Personalized Psychiatry market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Personalized Psychiatry.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Personalized Psychiatry market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Personalized Psychiatry Market by Company
COMPASS Pathways
Mindstrong Health
Pear Therapeutics
Cogito
Kaia Health
Sooma
GenoMind
Empatica
Akili Interactive
Neuroverse
Personalized Psychiatry Segment by Type
Depression and Anxiety
Bipolar Disorder
Addiction
Other
Personalized Psychiatry Segment by Application
Mental Health Professionals
Patients
Healthcare Providers
Personalized Psychiatry Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Psychiatry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Personalized Psychiatry and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Psychiatry.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Personalized Psychiatry companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Depression and Anxiety
- Bipolar Disorder
- Addiction
- Other
Applications
- Mental Health Professionals
- Patients
- Healthcare Providers
Companies covered
- COMPASS Pathways
- Mindstrong Health
- Pear Therapeutics
- Cogito
- Kaia Health
- Sooma
- GenoMind
- Empatica
- Akili Interactive
- Neuroverse
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Personalized Psychiatry Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Personalized Psychiatry Market Size by Region (2021-2032)
- 1.4.1 Global Personalized Psychiatry Market Size by Region (2021-2026)
- 1.4.2 Global Personalized Psychiatry Market Size by Region (2027-2032)
- 1.5 Key Regions Personalized Psychiatry Market Size (2021-2032)
- 1.5.1 North America Personalized Psychiatry Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Personalized Psychiatry Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Personalized Psychiatry Market Size Growth Rate (2021-2032)
- 1.5.4 South America Personalized Psychiatry Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Personalized Psychiatry Market Size Growth Rate (2021-2032)
2 Personalized Psychiatry Market by Type
- 2.1 Type Introduction
- 2.1.1 Depression and Anxiety
- 2.1.2 Bipolar Disorder
- 2.1.3 Addiction
- 2.1.4 Other
- 2.2 Global Personalized Psychiatry Market Size by Type
- 2.2.1 Global Personalized Psychiatry Market Size Overview by Type (2021-2032)
- 2.2.2 Global Personalized Psychiatry Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Personalized Psychiatry Market Size Forecasted by Type (2027-2032)
- 2.3 Global Personalized Psychiatry Market Size by Regions
- 2.3.1 North America Personalized Psychiatry Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Personalized Psychiatry Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Personalized Psychiatry Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Personalized Psychiatry Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Personalized Psychiatry Market Size Breakdown by Type (2021-2026)
3 Personalized Psychiatry Market by Application
- 3.1 Type Introduction
- 3.1.1 Mental Health Professionals
- 3.1.2 Patients
- 3.1.3 Healthcare Providers
- 3.2 Global Personalized Psychiatry Market Size by Application
- 3.2.1 Global Personalized Psychiatry Market Size Overview by Application (2021-2032)
- 3.2.2 Global Personalized Psychiatry Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Personalized Psychiatry Market Size Forecasted by Application (2027-2032)
- 3.3 Global Personalized Psychiatry Market Size by Regions
- 3.3.1 North America Personalized Psychiatry Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Personalized Psychiatry Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Personalized Psychiatry Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Personalized Psychiatry Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Personalized Psychiatry Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Personalized Psychiatry Industry Trends
- 4.2 Personalized Psychiatry Industry Drivers
- 4.3 Personalized Psychiatry Industry Opportunities and Challenges
- 4.4 Personalized Psychiatry Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Personalized Psychiatry Revenue (2021-2026)
- 5.2 Global Personalized Psychiatry Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Personalized Psychiatry Key Company Headquarters & Area Served
- 5.4 Global Personalized Psychiatry Company, Product Type & Application
- 5.5 Global Personalized Psychiatry Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Personalized Psychiatry Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Personalized Psychiatry Players Market Share by Revenue in 2025
- 5.6.3 2025 Personalized Psychiatry Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 COMPASS Pathways
- 6.1.1 COMPASS Pathways Company Information
- 6.1.2 COMPASS Pathways Business Overview
- 6.1.3 COMPASS Pathways Personalized Psychiatry Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 COMPASS Pathways Personalized Psychiatry Product Portfolio
- 6.1.5 COMPASS Pathways Recent Developments
- 6.2 Mindstrong Health
- 6.2.1 Mindstrong Health Company Information
- 6.2.2 Mindstrong Health Business Overview
- 6.2.3 Mindstrong Health Personalized Psychiatry Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Mindstrong Health Personalized Psychiatry Product Portfolio
- 6.2.5 Mindstrong Health Recent Developments
- 6.3 Pear Therapeutics
- 6.3.1 Pear Therapeutics Company Information
- 6.3.2 Pear Therapeutics Business Overview
- 6.3.3 Pear Therapeutics Personalized Psychiatry Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Pear Therapeutics Personalized Psychiatry Product Portfolio
- 6.3.5 Pear Therapeutics Recent Developments
- 6.4 Cogito
- 6.4.1 Cogito Company Information
- 6.4.2 Cogito Business Overview
- 6.4.3 Cogito Personalized Psychiatry Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Cogito Personalized Psychiatry Product Portfolio
- 6.4.5 Cogito Recent Developments
- 6.5 Kaia Health
- 6.5.1 Kaia Health Company Information
- 6.5.2 Kaia Health Business Overview
- 6.5.3 Kaia Health Personalized Psychiatry Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Kaia Health Personalized Psychiatry Product Portfolio
- 6.5.5 Kaia Health Recent Developments
- 6.6 Sooma
- 6.6.1 Sooma Company Information
- 6.6.2 Sooma Business Overview
- 6.6.3 Sooma Personalized Psychiatry Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Sooma Personalized Psychiatry Product Portfolio
- 6.6.5 Sooma Recent Developments
- 6.7 GenoMind
- 6.7.1 GenoMind Company Information
- 6.7.2 GenoMind Business Overview
- 6.7.3 GenoMind Personalized Psychiatry Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GenoMind Personalized Psychiatry Product Portfolio
- 6.7.5 GenoMind Recent Developments
- 6.8 Empatica
- 6.8.1 Empatica Company Information
- 6.8.2 Empatica Business Overview
- 6.8.3 Empatica Personalized Psychiatry Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Empatica Personalized Psychiatry Product Portfolio
- 6.8.5 Empatica Recent Developments
- 6.9 Akili Interactive
- 6.9.1 Akili Interactive Company Information
- 6.9.2 Akili Interactive Business Overview
- 6.9.3 Akili Interactive Personalized Psychiatry Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Akili Interactive Personalized Psychiatry Product Portfolio
- 6.9.5 Akili Interactive Recent Developments
- 6.10 Neuroverse
- 6.10.1 Neuroverse Company Information
- 6.10.2 Neuroverse Business Overview
- 6.10.3 Neuroverse Personalized Psychiatry Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Neuroverse Personalized Psychiatry Product Portfolio
- 6.10.5 Neuroverse Recent Developments
7 North America
- 7.1 North America Personalized Psychiatry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Personalized Psychiatry Market Size by Country (2021-2026)
- 7.3 North America Personalized Psychiatry Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Personalized Psychiatry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Personalized Psychiatry Market Size by Country (2021-2026)
- 8.3 Europe Personalized Psychiatry Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Personalized Psychiatry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Personalized Psychiatry Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Personalized Psychiatry Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Personalized Psychiatry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Personalized Psychiatry Market Size by Country (2021-2026)
- 10.3 South America Personalized Psychiatry Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Personalized Psychiatry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Personalized Psychiatry Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Personalized Psychiatry Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst